Subjects and Methods
The study included 21 patients with biopsy-proved primary intramedullary osteosarcoma. Four patients were imaged before initiation of preoperative chemotherapy, i 3 were at the midpoint of therapy, and four had completed chemotherapy at the time of MR imaging. In all patients, chemotherapy consisted of a 12-week period of high-dose methotrexate, cisplatin, and Adriamycin
[i]. MR images were acquired with a 0.3-T hybrid permanent resistive magnet. A surface coil was used for lesions of the knee and shoulder.
The field of view varied from 14 to 25 cm, depending on the body part under investigation. Slice thickness and interslice gap were chosen to cover the entire tumor, with 1 3 images provided for each pulse sequence.
Although multiplanar images were obtained in all patients, only axial images were evaluated for this study. In one patient, soft-tissue margins were poorly defined on both enhanced and unenhanced images. Unenhanced T2-weighted images in six of the i5 tumors with a capsule or pseudocapsule revealed poorly defined streaks of high signal intensity within adjacent muscle. In all six, there was gadopentetate dimeglumine enhancement in the same location (Fig. 3) , and in four, this enhancement was greater than the enhancement of the predominant soft-tissue mass itself. Of these four, surgical margins revealed that this enhancement represented peritumoral edema in two cases and tumor infiltration in two cases.
Neurovascular Involvement
The major neurovascular structures were clearly free of tumor in 15 patients. Comparison of unenhanced Ti -and T2-weighted images revealed tumor abutting the major bundles in five patients.
On enhanced Ti -weighted images, differentiation of tumorfrom normalfat surrounding the neurovascular bundle was less evident (Fig. 4) . In one patient, a major This article has been cited by:
